GO:0046485 ether lipid metabolic process

Ether lipids are a class of glycerophospholipids characterized by an ether bond between a fatty alcohol and the sn-1 position of glycerol, rather than the more common ester linkage. The Gene Ontology term GO:0046485, ether lipid metabolic process, encompasses the chemical reactions and pathways involving these lipids, including their biosynthesis, remodeling, and degradation. Ether lipids are found in all mammalian cells and are particularly abundant in the brain, heart, and immune cells, where they contribute to membrane structure, signaling, and antioxidant defense. The study of ether lipid metabolism has gained prominence because defects in this pathway are associated with peroxisomal disorders, cancer, and metabolic diseases. Ether lipid biosynthesis begins in peroxisomes, where dihydroxyacetone phosphate (DHAP) is acylated by GNPAT and then converted to alkyl-DHAP by AGPS. Subsequent reduction and dephosphorylation steps occur in the endoplasmic reticulum, generating the precursor alkylglycerol. The addition of a polar head group and desaturation of the alkyl chain produce plasmalogens, a major subclass of ether lipids. The pathway is tightly regulated and intersects with other lipid metabolic routes, including fatty acid synthesis and remodeling. Research on ether lipid metabolism is important for understanding membrane biology, cellular redox balance, and the pathogenesis of diseases such as rhizomelic chondrodysplasia punctata and certain cancers. Recent studies have also linked ether lipid deficiency to ferroptosis sensitivity, highlighting a role in cell death regulation. This article provides a comprehensive overview of GO:0046485, covering its definition, mechanism, key genes, disease associations, and experimental approaches for investigation.

GO:0046485, ether lipid metabolic process, is defined as the chemical reactions and pathways involving ether lipids, which are lipids that contain (normally) one lipid alcohol in ether linkage to one of the carbon atoms (normally C-1) of glycerol. This biological process includes the biosynthesis, modification, and breakdown of ether lipids such as plasmalogens, and it occurs primarily in peroxisomes and the endoplasmic reticulum.

Ether lipid metabolism is fundamental to cellular function because ether lipids, particularly plasmalogens, are essential components of cell membranes and are involved in membrane fusion, signaling, and protection against oxidative stress. Disruptions in this pathway can lead to severe developmental disorders and contribute to cancer progression and metabolic diseases. Understanding GO:0046485 is therefore critical for researchers studying lipid biology, peroxisomal function, and disease mechanisms.

The following genes encode enzymes and proteins directly involved in ether lipid metabolic process, as supported by published literature.

Ether lipid metabolism is regulated at multiple levels, including transcriptional control of biosynthetic enzymes and availability of substrates such as fatty alcohols and DHAP. Peroxisome proliferator-activated receptors (PPARs) influence the expression of genes involved in peroxisomal lipid metabolism, including ether lipid synthesis. Additionally, the pathway is sensitive to cellular redox status, as oxidative stress can affect enzyme activity and plasmalogen levels. Recent studies suggest that ether lipid metabolism is also regulated by feedback mechanisms that sense membrane lipid composition and ferroptosis sensitivity.

Defects in ether lipid biosynthesis are a hallmark of peroxisomal disorders such as rhizomelic chondrodysplasia punctata, which is caused by mutations in GNPAT, AGPS, or PEX7. These disorders lead to severe developmental abnormalities, including skeletal dysplasia and neurological impairment, due to impaired plasmalogen synthesis. Research on ether lipid metabolism is therefore critical for understanding the pathogenesis of these rare diseases.

Altered ether lipid metabolism has been observed in various cancers, where it can support tumor growth and survival. AGPS, a key enzyme in ether lipid synthesis, is overexpressed in some cancers and is considered a potential therapeutic target. Inhibiting ether lipid synthesis may reduce cancer cell proliferation and increase sensitivity to chemotherapy.

Ether lipid deficiency disrupts lipid homeostasis and increases sensitivity to ferroptosis, an iron-dependent form of cell death. This link suggests that ether lipid metabolism plays a protective role against oxidative stress in neurons, and its dysregulation may contribute to neurodegenerative diseases. Mouse models with ether lipid defects show altered lipidomes and increased vulnerability to ferroptosis inducers.

Mass spectrometry-based lipidomics is the primary method to quantify ether lipids, including plasmalogens, in cells and tissues. This approach can detect changes in lipid species resulting from genetic or pharmacological perturbations of ether lipid metabolism. It is often used in combination with knockout or overexpression models to assess pathway activity.

CRISPR-Cas9 is widely used to generate knockout, point-mutation, and knock-in models for studying ether lipid metabolism genes. For example, knockout of GNPAT or AGPS allows researchers to examine the consequences of ether lipid deficiency on cellular functions. Point mutations can mimic disease-associated variants, while knock-in of tags enables protein localization studies.

Fluorescence microscopy with tagged ether lipid enzymes or lipid probes can visualize the subcellular localization and dynamics of ether lipid metabolism. This is particularly useful for studying peroxisomal and endoplasmic reticulum steps. Live-cell imaging can reveal changes in lipid droplet formation or membrane organization upon pathway perturbation.

RNA sequencing (RNA-seq) is used to measure expression changes in genes involved in ether lipid metabolism under different conditions. It can identify transcriptional regulation and compensatory responses in knockout models. Integrating RNA-seq with lipidomics provides a systems-level view of the pathway.

Researchers studying ether lipid metabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or cellular phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.

GO:0046485, ether lipid metabolic process, is a vital biological pathway with broad implications for membrane biology, cellular stress responses, and human disease. Understanding its regulation and components offers opportunities for therapeutic intervention in peroxisomal disorders, cancer, and metabolic diseases. Continued research using advanced CRISPR models and lipidomics will further illuminate this pathway's roles.